anti-retroviral
Complementary and Alternative Medicine Use among HIV-Infected Patient’s on Anti-Retroviral Therapy in the Niger Delta Region, Nigeria
... on anti-retroviral therapy in the Niger Delta region are scarce in the scientific ...on anti-retroviral therapy in a rural Hospital in the Niger Delta region of ...
6
<p>The Prevalence of HIV-Positive Infants Born to HIV-Positive Mothers Attended at the University of Gondar Specialized Hospital Anti-Retroviral Therapy Services, Northwest Ethiopia, 2018</p>
... infected children, were reported in Sub-Saharan Africa in 2015. 4 Ethiopia is one of the countries in Sub-Saharan African with similar HIV cases. A cording to the 2016 WHO report showed that Ethiopia has, 720,000 people ...
6
Adherence to anti-retroviral therapy among HIV patients in Bangalore, India
... of anti-retroviral drugs (ARV) are the treatment of choice in HIV, and non-adherence is a main, if not the most important factor in treatment fail- ure, and the development of resistance ...
8
Beyond Communicable Diseases - Understanding the Adverse Habits and their Correlates among HIV Positive Patients on Anti Retroviral Therapy in Raichur Taluk, Karnataka, India
... any association with duration of illness, duration of Anti Retroviral Therapy regime and family support, the interplay of these factors cannot be neglected just because of lack of specific numbers. Those ...
7
Evaluation of quantitative liver function tests in HIV-positive patients under anti-retroviral therapy
... of anti-retroviral or liver-protective therapy in patients with liver disease caused by HIV- infection and additionally, it may be an economical method to follow up these patients - particularly those under ...
9
Tooth wear in patients treated with HIV anti-retroviral therapy
... At the Russell Street Clinic, patients were screened based on eligibility criteria as follows: at least 18 years of age, not pregnant, have at least 25 natural permanent teeth, HIV positive (HIV + ve) and on highly ...
7
Formulation Development and Characterization of Anti-Retroviral Agents
... In- vitro Drug Release from Anti retroviral Tablets:- In- Vitro dissolution studies were carried out using USP apparatus typeII at 50 rpm. Dissolution medium consist of 0.01N HCL maintained at 37ᵒC . Drug ...
5
Profile of patients undergoing third line anti-retroviral therapy
... with minimal risk of cross-resistance to previously used regimens such as Integrase strand transfer inhibitors (INSTIs) and second-generation NNRTIs and PIs. Under the national programme, it has been decided to provide ...
6
The effect of incident tuberculosis on immunological response of HIV patients on highly active anti retroviral therapy at the university of Gondar hospital, northwest Ethiopia: a retrospective follow up study
... Effective anti-retroviral therapy (ARV) therapy is usually convoyed by an increase in the number of CD4+ T - cells and the functional restoration of patents’ immune response and decline in HIV viral load as ...
8
Suboptimal Exposure to Anti-TB Drugs in a TBM/HIV+ Population is not Related to Anti-retroviral Therapy.
... In conclusion, there are three main findings that the work outlined herein has identified: Firstly, Antiretroviral therapy does not significantly interact with or change the exposure of any of the TB- drugs which ...
25
Dolutegravir-based anti-retroviral therapy is effective and safe in HIV–infected paediatric patients
... other anti-retroviral drugs and a potent activity against HIV-1 strains that are resistant to other INSTIs ...other anti-retroviral ...
5
Determinants of uncontrolled hypertension among clients on anti-retroviral therapy in Kadoma City, Zimbabwe, 2016
... ART: Anti-retroviral therapy; ARV: Anti-retroviral; BMI: Body mass index; BP: Blood pressure; CD4: Cluster of differentiation; CDC: Centers for Disease Control and Prevention; DALYS: ...
7
Implication of TRIMalpha and TRIMCyp in interferon induced anti retroviral restriction activities
... TRIMCyp-independent retroviral restriction activity in OMK ...The anti-Luc siRNA was used as con- ...on retroviral restriction following IFN-E ...All retroviral vectors were used at the same ...
15
ANTI-RETROVIRAL THERAPY OF HIV INFECTED PATIENTS
... start anti-retroviral therapy depends on the clinical or immunological ...starting anti-retroviral therapy if a patient presented with stage 3 or 4 though decisions based on such clinical ...
5
Economic evaluation of task-shifting approaches to the dispensing of anti-retroviral therapy
... The scarcity of human resources for health (HRH) has been identified as one of the primary constraints to the provision of anti-retroviral treatment (ART) to all who need it [1–3]. Pharmaceutical services ...
10
Effectiveness of HIV Anti-retroviral Agents on the HIV/AIDS Epidemic
... Aims: The scale up of HAART globally has shifted the mortality time table, decreased viral transmission and improved health related quality of life for patients [r] ...
13
Cost-effectiveness of anti-retroviral therapy at a district hospital in southern Ethiopia
... To deal with uncertainties related to the model structure and process, we performed scenario analysis under the following conditions: (a) if the initial distribution of patients in the n[r] ...
11
Magnitude of opportunistic infections and associated factors in HIV-infected adults on antiretroviral therapy in eastern Ethiopia
... Purpose: The aim of this study was to assess the prevalence of opportunistic infections (OIs) and associated factors among HIV-infected adults on anti-retroviral therapy (ART) in Hiwot[r] ...
8
HIV treatment is associated with a twofold higher probability of raised triglycerides: pooled analyses in 21 023 individuals in sub-Saharan Africa
... In primary analyses comparing individuals receiving ART to all other individuals, the magnitude of association between ART and raised TG ranged from 0.81 to 6.17, with a moder- ate level of heterogeneity (I 2 = 45.2%) ...
13
Impact of Chemotherapy on Immunological Parameters in HIV associated Malignancies
... Influence of highly active anti-retroviral therapy on response to treatment and survival in patients with acquired immunodeficiency syndrome related non-Hodgkin’s lymphoma treated with c[r] ...
75